PL377701A1 - Peptydy, które namierzają komórki nowotworowe i śródbłonkowe, kompozycje i ich zastosowania - Google Patents

Peptydy, które namierzają komórki nowotworowe i śródbłonkowe, kompozycje i ich zastosowania

Info

Publication number
PL377701A1
PL377701A1 PL377701A PL37770103A PL377701A1 PL 377701 A1 PL377701 A1 PL 377701A1 PL 377701 A PL377701 A PL 377701A PL 37770103 A PL37770103 A PL 37770103A PL 377701 A1 PL377701 A1 PL 377701A1
Authority
PL
Poland
Prior art keywords
peptides
compositions
endothelial cells
target tumor
tumor
Prior art date
Application number
PL377701A
Other languages
English (en)
Inventor
Amy L. Allan
Won Hyung Yoon
L.Patricia Gladstone
Robert J. Ternansky
Graham Parry
Fernando Donate
Andrew Mazar
Original Assignee
Attenuon, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Attenuon, Llc filed Critical Attenuon, Llc
Publication of PL377701A1 publication Critical patent/PL377701A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
PL377701A 2002-11-25 2003-11-25 Peptydy, które namierzają komórki nowotworowe i śródbłonkowe, kompozycje i ich zastosowania PL377701A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42917402P 2002-11-25 2002-11-25
US47553903P 2003-06-02 2003-06-02

Publications (1)

Publication Number Publication Date
PL377701A1 true PL377701A1 (pl) 2006-02-06

Family

ID=32397181

Family Applications (2)

Application Number Title Priority Date Filing Date
PL377763A PL377763A1 (pl) 2002-11-25 2003-11-25 Peptydy, które hamują angiogenezę, migrację komórek, naciekanie komórkowe i proliferację komórkową oraz kompozycje zawierające te peptydy i ich zastosowania
PL377701A PL377701A1 (pl) 2002-11-25 2003-11-25 Peptydy, które namierzają komórki nowotworowe i śródbłonkowe, kompozycje i ich zastosowania

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL377763A PL377763A1 (pl) 2002-11-25 2003-11-25 Peptydy, które hamują angiogenezę, migrację komórek, naciekanie komórkowe i proliferację komórkową oraz kompozycje zawierające te peptydy i ich zastosowania

Country Status (14)

Country Link
US (2) US20050020810A1 (pl)
EP (2) EP1569678A4 (pl)
JP (2) JP2006514116A (pl)
KR (2) KR20050096917A (pl)
AU (2) AU2003297609A1 (pl)
BR (2) BR0316523A (pl)
CA (2) CA2506813A1 (pl)
EA (2) EA200500871A1 (pl)
HR (2) HRP20050585A2 (pl)
MX (2) MXPA05005469A (pl)
NO (2) NO20053112L (pl)
NZ (2) NZ540363A (pl)
PL (2) PL377763A1 (pl)
WO (2) WO2004063213A2 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL377763A1 (pl) * 2002-11-25 2006-02-20 Attenuon, Llc. Peptydy, które hamują angiogenezę, migrację komórek, naciekanie komórkowe i proliferację komórkową oraz kompozycje zawierające te peptydy i ich zastosowania
CA2566897A1 (en) * 2004-05-21 2005-12-01 Mds Inc. Doing Business Through Its Mds Pharma Services Division Method of quantifying the cell-binding properties of a medical device
US20060078535A1 (en) * 2004-10-13 2006-04-13 The Regents Of The University Of Michigan Anticancer compounds and methods
EP1843779A2 (en) * 2005-02-01 2007-10-17 Attenuon, LLC Compositions containing the anti-angiogenic phscn-peptide
US20080261892A1 (en) 2005-02-01 2008-10-23 Ternansky Robert J Acid Addition Salts of Ac-Phscn-Nh2
AU2016213759B2 (en) * 2006-11-08 2018-03-29 Chongxi Yu Transdermal delivery systems of peptides and related compounds
AU2006350707A1 (en) * 2006-11-08 2008-05-15 Chongxi Yu Transdermal delivery systems of peptides and related compounds
PL2427475T3 (pl) 2009-05-08 2021-07-19 Techfields Biochem Co., Ltd. Kompozycje proleku o wysokim przenikaniu peptydów i związków powiązanych z peptydami
KR101228668B1 (ko) 2010-09-17 2013-01-31 가톨릭대학교 산학협력단 혈관신생 억제 활성을 갖는 펩타이드 및 이의 용도
WO2012178023A1 (en) 2011-06-23 2012-12-27 Board Of Regents, The University Of Texas System Identifying peptides at the single molecule level
US11435358B2 (en) 2011-06-23 2022-09-06 Board Of Regents, The University Of Texas System Single molecule peptide sequencing
CN102417540A (zh) * 2011-11-21 2012-04-18 中国药科大学 一种聚乙二醇修饰的整合素阻断剂hm-3及其应用
JP6206987B2 (ja) * 2012-05-11 2017-10-04 メディカス バイオサイエンシーズ，エルエルシー 網膜剥離の処置のための生体適合性ヒドロゲル製剤
CA2875369C (en) 2012-06-04 2017-11-21 Suncor Energy Inc. Formulations containing paraffinic oil and anti-settling agent
CA2877585C (en) 2013-03-15 2016-04-12 Suncor Energy Inc. Herbicidal compositions
JP5970439B2 (ja) * 2013-09-20 2016-08-17 チョンシー ユー ペプチド及び関連化合物の経皮送達システム
CA2961493C (en) * 2014-09-15 2023-10-03 Board Of Regents, The University Of Texas System Improved single molecule peptide sequencing
CN112513269A (zh) 2018-07-12 2021-03-16 德克萨斯大学系统董事会 通过寡核苷酸进行分子邻域检测
EP3861009A4 (en) 2018-10-05 2023-01-11 Board of Regents, The University of Texas System DETECTION AND RELEASE OF N-TERMINAL SOLID PHASE PEPTIDE
EP3923729B1 (en) 2019-02-15 2025-08-13 Nutrien Ag Solutions (Canada) Inc. The use of protoporphyrin ix derivatives to improve the health of plants

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
WO1981003330A1 (fr) 1980-05-13 1981-11-26 Mitsubishi Chem Ind Derives de la cysteine et leur production
US4440788A (en) * 1980-05-13 1984-04-03 Mitsubishi Chemical Industries, Limited Cysteine derivatives
US4394519A (en) * 1982-01-19 1983-07-19 Research Corporation Amino acid blocking agents
GB8504253D0 (en) * 1985-02-19 1985-03-20 Ici Plc Electrostatic spraying apparatus
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
DE3815221C2 (de) * 1988-05-04 1995-06-29 Gradinger F Hermes Pharma Verwendung einer Retinol- und/oder Retinsäureester enthaltenden pharmazeutischen Zubereitung zur Inhalation zur Einwirkung auf die Schleimhäute des Tracheo-Bronchialtraktes einschließlich der Lungenalveolen
US5091176A (en) * 1988-11-02 1992-02-25 W. R. Grace & Co.-Conn. Polymer-modified peptide drugs having enhanced biological and pharmacological activities
US5443816A (en) * 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
US5229366A (en) * 1990-10-23 1993-07-20 Fuji Photo Film Co., Ltd. Peptide-containing polyethylene glycol derivatives and application thereof
US5149801A (en) * 1990-11-21 1992-09-22 The Regents Of The University Of California Boronated porphyrin compounds
US5561220A (en) * 1991-02-08 1996-10-01 Diatech, Inc. Technetium-99m labeled peptides for imaging inflammation
US5698155A (en) * 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
US5556609A (en) * 1992-02-20 1996-09-17 Rhomed Incorporated YIGSR peptide radiopharmaceutical applications
US5608110A (en) * 1993-06-15 1997-03-04 Bracco International B.V. Heteroatom-bearing ligands and metal complexes thereof
US5639725A (en) * 1994-04-26 1997-06-17 Children's Hospital Medical Center Corp. Angiostatin protein
IL117474A (en) * 1995-03-14 2001-04-30 Siemens Ag Removable precise dosing unit containing inhaled drugs for a hearing aid device
ZA962077B (en) * 1995-03-14 1997-03-26 Siemens Ag Ultrasonic atomizer device with removable precision dosating unit
US5618513A (en) * 1995-06-07 1997-04-08 Mallinckrodt Medical, Inc. Method for preparing radiolabeled peptides
MY147327A (en) * 1995-06-29 2012-11-30 Novartis Ag Somatostatin peptides
CA2265484C (en) * 1996-09-10 2008-12-02 The Burnham Institute Tumor homing molecules, conjugates derived therefrom, and methods of using same
US6001965A (en) * 1996-11-21 1999-12-14 The Regents Of The University Of Michigan Anticancer compounds and methods
US6025150A (en) * 1996-11-21 2000-02-15 The Regents Of The University Of Michigan Methods and compositions for wound healing
US6331409B1 (en) * 1996-11-21 2001-12-18 The Regents Of The University Of Michigan Methods and compositions for wound healing
WO1998030538A1 (en) * 1997-01-14 1998-07-16 Kaneka Corporation Process for producing cysteine derivatives
US5994309A (en) * 1997-07-25 1999-11-30 Angstrom Pharmaceuticals, Inc. Anti-invasive and anti-angiogenic compositions and methods
AU9477398A (en) * 1997-09-10 1999-03-29 Burnham Institute, The Methods of identifying molecules that home to angiogenic vasculature in tumors
US5954047A (en) * 1997-10-17 1999-09-21 Systemic Pulmonary Development, Ltd. Methods and apparatus for delivering aerosolized medication
AU5671099A (en) * 1998-08-14 2000-03-06 The Administrators Of The Tulane Eductional Fund Compounds having growth hormone releasing activity
ATE366936T1 (de) 2001-01-18 2007-08-15 Univ Michigan Zusammensetzungen und verfahren zur verwendung von fibronektin-fragmenten bei krebsdiagnose
PL377763A1 (pl) 2002-11-25 2006-02-20 Attenuon, Llc. Peptydy, które hamują angiogenezę, migrację komórek, naciekanie komórkowe i proliferację komórkową oraz kompozycje zawierające te peptydy i ich zastosowania

Also Published As

Publication number Publication date
WO2004047771A2 (en) 2004-06-10
WO2004047771A3 (en) 2005-09-15
WO2004063213A2 (en) 2004-07-29
NO20053111D0 (no) 2005-06-24
WO2004063213A3 (en) 2005-03-03
US7517855B2 (en) 2009-04-14
CA2506813A1 (en) 2004-07-29
NO20053112D0 (no) 2005-06-24
AU2003298726A1 (en) 2004-08-10
KR20050096917A (ko) 2005-10-06
US20040162239A1 (en) 2004-08-19
EA200500871A1 (ru) 2006-04-28
JP2006514116A (ja) 2006-04-27
NO20053112L (no) 2005-08-05
BR0316550A (pt) 2005-10-04
EP1569678A2 (en) 2005-09-07
AU2003297609A1 (en) 2004-06-18
MXPA05005545A (es) 2005-10-18
NO20053111L (no) 2005-08-24
HRP20050585A2 (en) 2006-02-28
NZ540363A (en) 2007-11-30
BR0316523A (pt) 2005-10-18
EA200500870A1 (ru) 2006-04-28
US20050020810A1 (en) 2005-01-27
NZ540889A (en) 2008-09-26
KR20050097494A (ko) 2005-10-07
CA2507045A1 (en) 2004-06-10
JP2006515866A (ja) 2006-06-08
PL377763A1 (pl) 2006-02-20
HRP20050584A2 (hr) 2006-04-30
EP1569678A4 (en) 2008-01-02
EP1594521A4 (en) 2008-01-09
EP1594521A2 (en) 2005-11-16
MXPA05005469A (es) 2005-09-08

Similar Documents

Publication Publication Date Title
EP1569678A4 (en) PEPTIDES, THE TUMOR AND ENDOTHEL CELL CONTROLS, COMPOSITIONS AND ITS USES
EP1578930A4 (en) CNGH0004 POLYPEPTIDES, ANTIBODIES, COMPOSITIONS, METHODS AND USES
AU2003213246A1 (en) Bone targeting peptides
GB2387583B (en) Blast deflector
AU2003290563A8 (en) Leptin-related peptides
AU2003304180A8 (en) Growth arrest specific gene 6 peptides, antibodies, compositions, methods and uses
AU2003234210A1 (en) Direct cell target analysis
EP1539792A4 (en) CNGH0005 POLYPEPTIDES, ANTIBODIES, COMPOSITIONS, METHODS AND USES
IL156263A0 (en) Livin-derived peptides, compositions and uses thereof
EP1578783A4 (en) AIMING KNOWN BINDER
GB0324457D0 (en) Modified peptides and their uses
AU2003296663A1 (en) Endothelial cell specifically binding peptides
GB0326728D0 (en) Target
GB2387602B (en) Salt-sensitive polymer composition
AU2003290557A1 (en) Cell cycle targets and peptides
GB0218089D0 (en) Target DNA
GB0310243D0 (en) Target
GB0228694D0 (en) Novel threapeutic target
GB0312992D0 (en) Peptides,compositions and uses thereof
GB0219980D0 (en) Peptides
GB0217894D0 (en) Homing peptides
AU2003288442A8 (en) Trl1 as an antifungal target
GB0221392D0 (en) Target
GB0217853D0 (en) Target
AU2003299096A8 (en) Novel angiogenesis target and uses thereof

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)